ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-456-15), and b) …
| Source | FDA · Drugs (US) |
|---|---|
| Date | 2026-09-02 |
| Product | Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), packaged in a) 90-count bottles (NDC 16729-456-15), and b) 1000-count bottles (NDC 16729-456-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India. |
| Reason / hazard | Subpotent Drug |
| Classification | Class II |
| Official notice | — |
| Record ID | fda-drug:D-0784-2026 |